La influencia de los psicofármacos en la conducción

Referencias bibliográficas

• Ahlm, K., Björnstig, U. & Oström, M. (2009) Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden. Accid Anal Prev. Jan;41(1):129-36.
• Allgulander, C., Bandelow, B., Hollander, E., Montgomery, S.A., Nutt, D.J., Okasha, A., Pollack, M.H., Stein, D.J. & Swinson, R.P. (2003). World Council of Anxiety. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. Aug;8(8 Suppl 1):53-61. Review.
• Badawi, N., Simonsen, K.W., Steentoft, A., Bernhoft, I.M. & Linnet K. (2009). Simultaneous screening and quantifi cation of 29 drugs of abuse in oral fl uid by solid-phase extraction LC-MS/MS. Clin Chem. Nov;55(11):2004-18. Epub 2009 Oct 1.
• Berthelon, C., Longcamp, A., Coquerel, A., & Denise, P (2008). Residual eff ects of zolpidem, zopiclone and flunitrazepam on the processing of visual information in driving contex. European Review of Applied Psychology. Volume 58, Issue 2, June 2008, Pages 111-116.
• Bogan, R.K. (2008). Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefi t next-day performance. Postgrad Med. Sep;120(3):161-71.
• Bosker, W.M. & Huestis, M.A. (2009). Oral fl uid testing for drugs of abuse. Clin Chem. Nov;55(11):1910-31. Epub 2009 Sep 10.
• Bramness, J.G., Skurtveit, S., Neutel, C.I., Mørland, J. & Engeland, A. (2009). An increased risk of road traffi c accidents after prescriptions of lithium or valproate? Pharmacoepidemiol Drug Saf. Jun;18(6):492-6.
• Bramness, J.G., Skurtveit, S., Neutel, C.I., Mørland, J. & Engeland, A. (2008). Minor increase in risk of road traffi c accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiatry. Jul;69(7):1099-103.
• Bramness, J.G., Skurtveit, S. & Mørland, J. (2006). Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions. Forensic Sci Int. Jun 2;159(2-3):83-91.
• Brunnauer, A., Laux, G.& Zwick, S. (2009). Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics. Eur Arch Psychiatry Clin Neurosci. Dec;259(8):483-9.
• Brunnauer, A., Laux, G., David, I., Fric, M., Hermisson, I. & Möller, H.J. (2008). The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. J Clin Psychiatry. Dec;69(12):1880-6.
• Brunnauer, A., Laux, G., Geiger, E., Soyka, M. & Möller, H.J. (2006). Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry. Nov;67(11):1776-81.
• Cano Vindel, A., Iruarrizaga, I., Ramos, J., Dongil, E., Mae Wood, C. y Salguero, M. (en prensa). Estrés, ansiedad, depresión y vulnerabilidad al accidente. En F. Tortosa Gil y C. Civera-Mollá (Dirs.). Prevención de Riesgos en los Comportamientos Viales II. Valencia: Precovir.
• Ch’ng, C.W., Fitzgerald, M., Gerostamoulos, J., Cameron, P., Bui, D., Drummer, O.H., Potter, J. & Odell, M. (2007). Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre. Emerg Med Australas;19(4):359-65, 2007 Aug.
• Christophersen, A.S & Mørland, J. (2008). Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev. Jun;9(2):98-104.
• Dubois, S., Bédard, M. & Weaver, B. (2008). The impact of benzodiazepines on safe driving. Traffi c Inj Prev. 2008 Oct;9(5):404-13.
• EMCDDA (2009) Annual report on the state of the drugs problem in Europe, Lisbon, November 2009.
• Engeland, A., Skurtveit, S. & Mørland J. (2007). Risk of road traffi c accidents associated with the prescription of drugs: a registrybased cohort study. Ann Epidemiol. 2007 Aug;17(8):597-602.
• Geiger, E., Brunnauer, A. & Laux, G. (2007). Driving Ability in Schizophrenic Patients - Stability and Course. Psychiat Prax; 34: S87-S89.
• Gibson, J.E., Hubbard, R.B., Smith, C.J., Tata, L.J., Britton, J.R. & Fogarty, A.W. (2009). Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol. Mar 15;169(6):761-8.
• Gjerde, H., Normann, P.T., Pettersen, B.S., Assum, T., Aldrin, M., Johansen, U., Kristoff ersen, L., Øiestad, E.L., Christophersen, A.S. & Mørland, J. (2008). Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev. Sep;40(5):1765-72.
• Gustavsen, I., Al-Sammurraie, M., Mørland, J. & Bramness, J.G. (2009). Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev. May;41(3):462-6.
• Hadidi, M.S, Ibrahim. M.I., Abdallat, I.M. & Hadidi, K.A. (2009). Current trends in drug abuse associated fatalities - Jordan, 2000-2004. Forensic Sci Int. Apr 15;186(1-3):44-7.
• Haro, J.M., Palacín, C., Vilagut, G., Martínez, M., Bernal, M., Luque, I., Codony, M., Dolz, M., Dolz, M. & Alonso, J. (2006). Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Medicina clínica; 126(12).
• Holmgren, A., Holmgren, P., Kugelberg, F.C., Jones, A.W. & Ahlner, J. (2007). Predominance of illicit drugs and poly-drug use among drugimpaired drivers in Sweden. Traffi c Inj Prev. Dec;8(4):361-7.
• Hooper, T.I., DeBakey, S.F., Pearse, L., Pratt, S. & Hoff man, K.J. (2010). The use of electronic pharmacy data to investigate prescribed medications and fatal motor vehicle crashes in a military population, 2002-2006. Accid Anal Prev. Jan;42(1):261-8.
• Huynh, K., Wang, G., Moore, C., Barhate, R., Coulter, C., Rodrigues, W., Catbagan, P. & Soares, J. (2009). Development of a homogeneous immunoassay for the detection of zolpidem in urine. J Anal Toxicol. Oct;33(8):486-90.
• Ingsathit, A., Woratanarat, P., Anukarahanonta, T., Rattanasiri, S., Chatchaipun, P., Wattayakorn, K., Lim, S. & Suriyawongpaisal, P. (2009). Prevalence of psychoactive drug use among drivers in Thailand: A roadside survey. Accident Analysis & Prevention. Vol. 41, no. 3, pp. 474-478. May.
• Instituto nacional de toxicología y ciencias forenses (2008). Memoria análisis toxicológico muertes 2008.
• Iwamoto, K., Kawamura, Y., Takahashi, M., Uchiyama, Y., Ebe, K., Yoshida, K., Iidaka, T., Noda, Y. & Ozaki N. (2008). Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers. Psychiatry Clin Neurosci. Oct;62(5):610-6.
• Iwersen-Bergmann, S., Andresen, H., Püschel, K., Heinemann, A. & Renteln-Kruse, W. (2009). Use of psychotropic substances by the elderly and driving accidents. Z Gerontol Geriatr. Jun;42(3):193-204.
• Jones, A.W., Kugelberg, F.C., Holmgren, A. & Ahlner, J. (2009). Five-year update on the occurrence of alcohol and other drugs in blood samples from drivers killed in roadtraffi c crashes in Sweden. Forensic Sci Int. Apr 15;186(1-3):56-62. Epub Feb 18.
• Jones, A.W., Holmgren, A. & Kugelberg, F.C. (2007). Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther Drug Monit. Apr;29(2):248-60.
• Karjalainen, K.K., Lintonen, T.P., Impinen, A.O., Lillsunde, P.M. & Ostamo, A.I. (2010). Poly-drug fi ndings in drugged driving cases during 1977–2007. Journal of Substance Use. Vol 15(2), Apr 2010, pp. 143-156.
• Keller, T., Keller, A., Tutsch-Bauer, E. & Monticelli, F. (2009). Driving under the infl uence of drugs and alcohol in Salzburg and Upper Austria during the years 2003-2007. Leg Med (Tokyo). Apr;11 Suppl 1:S98-9.
• Kirschbaum, K.M., Musshoff , F., Wilbert, A., Röhrich, J. & Madea, B. (2010). Direct ELISA kits as a sensitive and selective screening method for abstinence control in urine. Forensic Sci Int. Oct 6.
• Matza, L.S., Buchanan, R., Purdon, S., Brewster-Jordan, J., Zhao, Y. & Revicki, D.A. (2006). Measuring changes in functional status among patients with Schizophrenia: the link with cognitive impairment. Schizophr Bull. Oct;32(4):666-78.
• Mravcík, V., Zábransky, T. & Vorel, F. (2010). Ethanol and other psychoactive substances in fatal road traffi c accidents in the Czech Republic in 2008. Cas Lek Cesk;149(7):332-6.
• Mravcík, V., Vorel, F. & Zábranský, T. (2007). Drugs and fatal traffic accidents in the Czech Republic. Cent Eur J Public Health. Dec;15(4):158-62.
• Officer J. (2009). Trends in drug use of Scottish drivers arrested under Section 4 of the Road Traffic Act--a 10 year review. Sci Justice. Dec;49(4):237-41.
• Orriols, L., Salmi, L.R., Philip, P., Moore, N., Delorme, B., Castot, A. & Lagarde, E. (2009). The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf. Aug;18(8):647-58
• Papadodima, S.A, Athanaselis, S.A., Stefanidou, M.E., Dona, A.A., Papoutsis, I., Maravelias, C.P. & Spiliopoulou C.A. (2008). Driving under the infl uence in Greece: a 7-year survey (1998- 2004). Forensic Sci Int. Jan 30;174(2-3):157-60.
• Pehrsson, A., Gunnar, T., Engblom, C., Seppä, H., Jama, A., Lillsunde, P. (2008). Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confi rmation results of oral fl uid and whole blood. Forensic Sci Int. Mar 5;175(2-3):140-8.
• Pil, K. & Verstraete, A. (2008). Current developments in drug testing in oral fl uid. Ther Drug Monit. Apr;30(2):196-202.
• Rapoport, M.J., Lanctôt, K.L., Streiner, D.L., Bédard, M., Vingilis, E., Murray, B., Schaff er, A., Shulman, K.I. & Herrmann, N. (2009). Benzodiazepine use and driving: a meta-analysis. Clin Psychiatry. 2009 Apr 21;70(5):663-73.
• Rapoport, M.J. & Baniña, M.C. (2007). Impact of psychotropic medications on simulated driving: a critical review. CNS Drugs. 2007;21(6):503-19.
• Ravera, S., Hummel, S.A., Stolk, P., Heerdink, R.E., de Jong-van den Berg, L.T.W. & de Gier, J.J. (2009). The use of driving impairing medicines: a European survey. European Journal of Clinical Pharmacology 1139-1147
• Ricci, G., Majori, S., Mantovani, W., Zappaterra, A., Rocca, G. & Buonocore, F. (2008). Prevalence of alcohol and drugs in urine of patients involved in road accidents. J Prev Med Hyg. Jun;49(2):89-95.
• Sagberg, F. (2006). Driver health and crash involvement: a case-control study. Accid Anal Prev. Jan;38(1):28-34.
• Santamariña-Rubio, E., Pérez, K., Ricart, I., Rodríguez-Sanz, M., Rodríguez-Martos, A., Brugal, M.T., Borrell, C., Ariza, C., Díez, E., Beneyto, V.M., Nebot, M., Ramos, P. & Suelves, J.M. (2009). Substance use among road traffi c casualties admitted to emergency departments. Inj Prev. Apr;15(2):87-94.
• Senna ,M.C, Augsburger, M., Aebi, B., Briellmann, T.A., Donzé, N., Dubugnon, J.L., Iten, P.X., Staub, C., Sturm, W., Sutter, K. (2010). First nationwide study on driving under the infl uence of drugs in Switzerland. Forensic Sci Int. May 20;198(1-3):11-6.
• Shen, J., Moller, H.J,, Wang, X., Chung, S.A., Shapiro, G.K., Li, X. & Shapiro, C.M. (2009), Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. J Clin Psychiatry. Mar;70(3):370-7.
• Siliquini, R., Chiadò, Piat, S., Gianino, M.M. & Renga G. (2007) Drivers involved in road traffi c accidents in Piedmont Region: psychoactive substances consumption. J Prev Med Hyg. 2007 Dec;48(4):123-8.
• Siriwardena, A.N, Qureshi, Z., Gibson, S., Collier, S. & Latham, M. (2006). GPs’ attitudes to benzodiazepine and ‘Z-drug’ prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract. Dec;56(533):964-7.
• Smink, B.E, Egberts, A.C, Lusthof, K.J., Uges, D.R. & de Gier J.J. (2010). The relationship between benzodiazepine use and traffi c accidents: A systematic literature review. CNS Drugs. Aug 1;24(8):639-53.
• Smink, B.E., Movig, K.L., Lusthof, K.J., De Gier, J.J., Uges, D.R. & Egberts, A.C. (2008). The relation between the use of psychoactive substances and the severity of the injury in a group of crash-involved drivers admitted to a regional trauma center. Traffi c Inj Prev. Jun;9(2):105-8.
• Smink, B.E., Lusthof, K.J., de Gier, J.J., Uges, D.R., Egberts, A.C. (2008). The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers. J Forensic Leg Med. Nov;15(8):483-8.
• Veldhuijzen, D.S., van Wijck, A.J., Verster, J.C., Kenemans, J.L., Kalkman, C.J., Olivier, B. & Volkerts, E.R. (2006). Acute and subchronic eff ects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients. J Psychopharmacol. Nov;20(6):782-8.
• Verster, J.C., Veldhuijzen, D.S., Patat, A., Olivier, B. & Volkerts, E.R. (2006). Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf. Jan;1(1):63-71.
• Volná, J. & Sonka, K. (2006). Medical factors of falling asleep behind the wheel. Prague Med Rep. 2006;107(3):290-6.
• Wille, S.M., Raes, E., Lillsunde, P., Gunnar, T., Laloup, M., Samyn, N., Christophersen, A.S., Moeller, M.R., Hammer, K.P., Verstraete, A.G. (2009). Relationship between oral fl uid and blood concentrations of drugs of abuse in drivers suspected of driving under the infl uence of drugs. Ther Drug Monit. Aug;31(4):511-9.
• Wingen, M., Ramaekers, J.G., Schmitt, J.A. (2006). Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology (Berl). Sep;188(1):84-91
• Zammit, G. (2009). Comparative tolerability of newer agents for insomnia. Drug Saf. ;32(9):735-48.